HSKA  valuation analysis

Name: Heska Corporation
Description: Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Feb 23, 2021
Market cap: $1.71B (660th)
Sales(TTM): $197.32M (813th)
Earnings(TTM): -$14.75M (678th)

FFER: 1.40 (why)
Actual price: $180.80
FFEThis is Heska Corporation's the estimated price. FFEs are the denominator of the FFER ratio.: $136.77
Quantile: HSKA is very expensive given its fundamentals.
Prices as of EOD 2021-05-12
Price & Estimates
Sales & Earnings history (TTM)
  • Heska Corporation's sales grew by 60.9% ($122.66M to $197.32M) over one year against a market average growth of 3.5%.
  • Heska Corporation's operating income decreased from $327,000 to -$8.19M in the last year.
Earnings / MarketCap
Heska Corporation
"Diagnostics & Research" industry
Sales / MarketCap
Heska Corporation
"Diagnostics & Research" industry
Book / MarketCap
Heska Corporation
"Diagnostics & Research" industry
Equity / Assets
Heska Corporation
"Diagnostics & Research" industry